Comparison of characteristics and outcomes of dabigatran versus warfarin in hypertensive patients with atrial fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack… - The American journal of …, 2015 - Elsevier
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …
被引用次数：74 相关文章

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack… - American Journal of …, 2015 - hero.epa.gov
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …

[引用][C] Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack… - The American Journal …, 2015 - cir.nii.ac.jp
Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive
Patients With Atrial Fibrillation (from the RE-LY Trial) | CiNii Research CiNii 国立情報学研究所 …

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).

R Nagarakanti, L Wallentin, H Noack… - The American Journal …, 2015 - europepmc.org
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack, M Brueckmann… - 2015 - pubmed.ncbi.nlm.nih.gov
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack… - The American Journal of …, 2015 - infona.pl
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack… - … American Journal of …, 2015 - search.proquest.com
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack… - American Journal of …, 2015 - ajconline.org
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)

R Nagarakanti, L Wallentin, H Noack… - American Journal of …, 2015 - diva-portal.org
Hypertension is frequent in patients with atrial fibrillation (AF) and is an independent risk
factor for stroke. The Randomized Evaluation of Long Term Anticoagulant TherapY (RE-LY) …